Pi Health is to deliver outsourced clinical research services in a GSK oncology study to enhance the efficiency and speed of ...

On 24 September, uniQure announced positive topline results from its pivotal Phase I/II studies (HD-GENE-TRX1, HD-GENE-TRX2) ...

As China's biotech sector continues to buzz with innovation, the country is rapidly integrating into the global clinical ...

Bayer vice president Luiz Barberini explains how the German giant’s cooperation with suppliers fosters long-term trial ...

In a pair of Phase III trials, J&J and Protagonists' icotrokinra beat BMS' Sotyktu on every skin-clearness measure.

Datavant has partnered with life sciences commercialisation firm Indegene to enhance recruitment of subjects for clinical ...

AstraZeneca’s Saphnelo (SC) administration has shown a decrease in disease activity in individuals with systemic lupus ...

Nektar Therapeutics has presented data of its atopic dermatitis (AD) candidate rezpeg (rezpegaldesleukin), which sent the ...

Kairos Pharma has reported encouraging interim efficacy data from its Phase II study of ENV105 in individuals with mCRPC.

REDCap Cloud (nPhase) has introduced a new platform to unify real-world evidence with clinical study data within a single ...

The main concerns about tariffs that businesses have are higher input costs and uncertainty in long-term planning.

PepGen’s stock has risen by over 120% after its investigational myotonic DM1 candidate reported the highest mean splicing correction in a Phase I trial.